Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells.
Wei D, Zhang G, Zhu Z, Zheng Y, Yan F, Pan C, Wang Z, Li X, Wang F, Meng P, Zheng W, Yan Z, Zhai D, Lu Z, Yuan J.
Wei D, et al. Among authors: zheng w, zheng y.
Front Pharmacol. 2019 Jul 9;10:690. doi: 10.3389/fphar.2019.00690. eCollection 2019.
Front Pharmacol. 2019.
PMID: 31354472
Free PMC article.